Skip to main content

Autoinjectors Market | Newest Industry Data, Future Trends and Forecast 2023

Autoinjectors are used to self-administer drugs for the treatment of various diseases and conditions, such as rheumatoid arthritis, multiple sclerosis, diabetes, and anaphylaxis. Autoinjectors are easy to use, portable, and improve dosing accuracy, making them one of the most popular methods for the self-administration of drugs.

The global autoinjectors market is projected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2% during the forecast period (2018-2023).

In terms of Therapy, the global autoinjectors market can be segmented into:

  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Diabetes
  • Anaphylaxis
  • Other Therapies (Cardiovascular Diseases, Migraines, Psoriasis, and Anemia)

By therapy, the rheumatoid arthritis segment is expected to account for the largest share of the market in 2018

On the basis of therapy, the autoinjectors market is segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and other therapies such as migraines, cardiovascular diseases, psoriasis, and anemia. In 2018, the rheumatoid arthritis segment is expected to account for the largest share of the global market. The large share of this segment can be primarily attributed to the high prevalence of rheumatoid arthritis across the globe.

Get a sample PDF copy of the Report @: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173991724


Browse and in-depth TOC on "Autoinjectors Market"
66 - Tables
36 - Figures
133 - Pages

The geographical regions mapped in the report are:

  • North America
  • Europe
  • APAC
  • Rest of the World

North America to dominate the market in 2018
In 2018, North America is expected to account for the largest share of the autoinjectors market, followed by Europe. Factors such as increasing geriatric population in Canada, increasing FDA approvals, rising prevalence of anaphylaxis in the US, and rising prevalence of autoimmune and chronic diseases in the US and Canada are contributing to the large share of North America.

Some key players mentioned in the research report are:

The key players in the global autoinjectors market are Abbvie (US), Amgen (US), Teva (Israel), Biogen (US), Eli Lilly (US), and Mylan (US). The other prominent players in the market are J&J (US), Novartis (Switzerland), Bayer (Germany), Merck (Germany), Biogen (US), Ypsomed (Switzerland), SHL Group (Taiwan) Becton, Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), and Haselmeier (Switzerland).

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=173991724

Labels:

Comments

Post a Comment

Popular posts from this blog

Biomaterials Market To Reach USD 47.5 billion by 2025 - Rising demand for medical implants

  What This Report Will Provide? This study involved four major activities in estimating the current size of the biomaterials market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Expected Revenue Growth: [298 Pages Report]  The global  biomaterials market  size is projected to reach USD 47.5 billion by 2025 from USD 35.5 billion in 2020, at a CAGR of 6.0% during the forecast period. Major Growth Boosters: Market growth is driven mainly by factors such as the increased funds & grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases, increasing res...
Post a Comment
Read more

Benefits of Best Accounting Software by 360Quadrants

  Accounting software  can manage the businesses in several different ways, based on the key characteristics and goals. Accounting systems provide all kinds of bonuses, from simpler invoicing to complicated tax reporting, that is not even possible without a correct framework. Simplification  - Accounting software put control of funds in the hands of a non-accounting crowd, aimed at giving significance to statistics while executing electronic computations. With hardly any training, the company owner can execute all financial transactions and meet the legal requirements from a desktop computer or smartphone, even without having to pay a third party to keep the expenditure in the loop. Cost reduction  - Accounting and finance frameworks simplify key estimates and operating processes and gain a charge of the sales process and you don't need to outsource financial services to an external specialist. They also raise printing and storage prices and store confidential data i...
Post a Comment
Read more

Biomaterials Market To Reach $ 47.5 Billion – Increasing Research On Regenerative Medicine

  Market growth is driven mainly by factors such as the increased funds & grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases, increasing research on regenerative medicine. In addition, high growth is expected for plastic surgery and wound healing applications, which will further drive the growth of the biomaterials market in the coming years. [298 Pages Report]  The  global biomaterials market  size is projected to reach USD 47.5 billion by 2025 from USD 35.5 billion in 2020, at a CAGR of 6.0% during the forecast period. Market Dynamics Increased funds and grants by government bodies and universities for the development of novel biomaterials Increasing demand for implantable devices Growing demand for biomaterials in plastic surgery and wound healing applications Rising incidence of cardiovascular diseases Increasing research on regenerative medic...
Post a Comment
Read more